Tibet Rhodiola Pharmaceutical Holding Co. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 494.293 million compared to CNY 296.779 million a year ago. Operating income was CNY 176.402 million compared to CNY 144.765 million a year ago. Net income was CNY 157.178 million compared to CNY 128.531 million a year ago. Basic earnings per share from continuing operations was CNY 0.63 compared to CNY 0.73 a year ago.